- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
SleepWell intervention can prevent Psychotic Experiences in Youth at Risk: Lancet
Sleep disruption has long been linked to mental health issues, and a recent study has shed light on its potential impact on young people at ultra-high risk of psychosis. The results were published in The Lancet Psychiatry.
The study by researchers from National Health Service (NHS) trusts in England, aimed to assess the feasibility and acceptability of a randomized controlled trial targeting sleep problems to mitigate psychotic experiences in this vulnerable population.
The research, which spanned from November 2020 to January 2022, screened 67 young individuals, of whom 40 (60%) at ultra-high risk of psychosis were enrolled. The participants, aged between 14 and 25, were already patients of mental health services and displayed sleep problems, a common issue associated with mental health disturbances.
The trial employed a single-blind, parallel-group design where participants were randomly assigned to either receive the targeted psychological sleep therapy (SleepWell) in addition to usual care, or just usual care. SleepWell therapy involved approximately eight hour-long sessions delivered over a 12-week period. The efficacy of this approach was measured at 3 and 9 months, showing a reduction in insomnia severity in the SleepWell group compared to the usual care group.
Crucially, the study demonstrated the feasibility of conducting a randomized controlled trial in this delicate population. The participants' retention rate was notably high, with 98% completing the primary outcome assessment at both 3 and 9 months. Furthermore, 95% of those assigned to the SleepWell therapy adhered to the recommended treatment schedule.
The study's results bring hope to the field of early intervention for mental health issues, offering a possible avenue for preventing the progression of psychosis in vulnerable youth. As a next step, researchers are calling for a definitive multicenter trial to establish the broader effectiveness and benefits of the SleepWell therapy.
Source:
Waite, F., Černis, E., Kabir, T., Iredale, E., Johns, L., Maughan, D., Diamond, R., Seddon, R., Williams, N., Yu, L.-M., & Freeman, D. (2023). A targeted psychological treatment for sleep problems in young people at ultra-high risk of psychosis in England (SleepWell): a parallel group, single-blind, randomised controlled feasibility trial. In The Lancet Psychiatry (Vol. 10, Issue 9, pp. 706–718). Elsevier BV. https://doi.org/10.1016/s2215-0366(23)00203-1
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751